Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.
Business Model:
Revenue: $17.9M
Employees: 11-50
Transition Therapeutics was acquired by
OPKO Health.
The acquisition happend on 2016-06-30.
Details of the transaction were not public
Address: 101 College Street
City: Toronto
State: ontario
Zip: M5G 1L7
Country: CA
Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.
Contact Phone:
+14162607770
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/31/2007
Ticker Symbol:
TTHI
Amount Raised:
$22M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2013 | Post-IPO Equity | 1 | $11M |
Larry N. Feinberg Larry N. Feinberg |
6/2014 | Post-IPO Equity | $0 |
Jack W. Schuler Living Trust Larry N. Feinberg Oracle Investment Management Inc. Jack W. Schuler Living Trust Larry N. Feinberg Oracle Investment Management Inc. |
6/2014 | Post-IPO Equity | 3 | $30.8M |
Jack W. Schuler Living Trust Larry N. Feinberg Oracle Investment Management Inc. Jack W. Schuler Living Trust Larry N. Feinberg Oracle Investment Management Inc. |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|